Literature DB >> 23258539

Parkin ubiquitinates Tar-DNA binding protein-43 (TDP-43) and promotes its cytosolic accumulation via interaction with histone deacetylase 6 (HDAC6).

Michaeline L Hebron1, Irina Lonskaya, Kaydee Sharpe, Puwakdandawe P K Weerasinghe, Norah K Algarzae, Ashot R Shekoyan, Charbel E-H Moussa.   

Abstract

The importance of E3 ubiquitin ligases, involved in the degradation of misfolded proteins or promotion of protein-protein interaction, is increasingly recognized in neurodegeneration. TDP-43 is a predominantly nuclear protein, which regulates the transcription of thousands of genes and binds to mRNA of the E3 ubiquitin ligase Parkin to regulate its expression. Wild type and mutated TDP-43 are detected in ubiquitinated forms within the cytosol in several neurodegenerative diseases. We elucidated the mechanisms of TDP-43 interaction with Parkin using transgenic A315T mutant TDP-43 (TDP43-Tg) mice, lentiviral wild type TDP-43, and Parkin gene transfer rat models. TDP-43 expression increased Parkin mRNA and protein levels. Lentiviral TDP-43 increased the levels of nuclear and cytosolic protein, whereas Parkin co-expression mediated Lys-48 and Lys-63-linked ubiquitin to TDP-43 and led to cytosolic co-localization of Parkin with ubiquitinated TDP-43. Parkin and TDP-43 formed a multiprotein complex with HDAC6, perhaps to mediate TDP-43 translocation. In conclusion, Parkin ubiquitinates TDP-43 and facilitates its cytosolic accumulation through a multiprotein complex with HDAC6.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23258539      PMCID: PMC3567661          DOI: 10.1074/jbc.M112.419945

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  77 in total

1.  The seeds of neurodegeneration: prion-like spreading in ALS.

Authors:  Magdalini Polymenidou; Don W Cleveland
Journal:  Cell       Date:  2011-10-28       Impact factor: 41.582

Review 2.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

3.  Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation.

Authors:  Eyal Avraham; Ruth Rott; Esti Liani; Raymonde Szargel; Simone Engelender
Journal:  J Biol Chem       Date:  2007-02-27       Impact factor: 5.157

4.  PINK1 controls mitochondrial localization of Parkin through direct phosphorylation.

Authors:  Yongsung Kim; Jeehye Park; Sunhong Kim; Saera Song; Seok-Kyu Kwon; Sang-Hee Lee; Tohru Kitada; Jin-Man Kim; Jongkyeong Chung
Journal:  Biochem Biophys Res Commun       Date:  2008-10-26       Impact factor: 3.575

5.  Parkinson-related parkin reduces α-Synuclein phosphorylation in a gene transfer model.

Authors:  Preeti J Khandelwal; Sonya B Dumanis; Li Rebekah Feng; Kathleen Maguire-Zeiss; Gw Rebeck; Hilal A Lashuel; Charbel Eh Moussa
Journal:  Mol Neurodegener       Date:  2010-11-04       Impact factor: 14.195

6.  Parkin reverses intracellular beta-amyloid accumulation and its negative effects on proteasome function.

Authors:  Kenneth M Rosen; Charbel E-H Moussa; Han-Kyu Lee; Pravir Kumar; Tohru Kitada; Gangjian Qin; Qinghao Fu; Henry W Querfurth
Journal:  J Neurosci Res       Date:  2010-01       Impact factor: 4.164

7.  Amyotrophic lateral sclerosis-plus syndrome with TAR DNA-binding protein-43 pathology.

Authors:  Leo F McCluskey; Lauren B Elman; Maria Martinez-Lage; Vivianna Van Deerlin; Wuxing Yuan; Dana Clay; Andrew Siderowf; John Q Trojanowski
Journal:  Arch Neurol       Date:  2009-01

8.  Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Masato Hasegawa; Tetsuaki Arai; Takashi Nonaka; Fuyuki Kametani; Mari Yoshida; Yoshio Hashizume; Thomas G Beach; Emanuele Buratti; Francisco Baralle; Mitsuya Morita; Imaharu Nakano; Tatsuro Oda; Kuniaki Tsuchiya; Haruhiko Akiyama
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

9.  Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.

Authors:  Hanae Nakashima-Yasuda; Kunihiro Uryu; John Robinson; Sharon X Xie; Howard Hurtig; John E Duda; Steven E Arnold; Andrew Siderowf; Murray Grossman; James B Leverenz; Randy Woltjer; Oscar L Lopez; Ronald Hamilton; Debby W Tsuang; Douglas Galasko; Eliezer Masliah; Jeffrey Kaye; Christopher M Clark; Thomas J Montine; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2007-07-25       Impact factor: 17.088

10.  Parkin promotes intracellular Abeta1-42 clearance.

Authors:  Mark P Burns; Lihua Zhang; G William Rebeck; Henry W Querfurth; Charbel E-H Moussa
Journal:  Hum Mol Genet       Date:  2009-05-29       Impact factor: 6.150

View more
  58 in total

Review 1.  TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration.

Authors:  Ju Gao; Luwen Wang; Tingxiang Yan; George Perry; Xinglong Wang
Journal:  Mol Cell Neurosci       Date:  2019-08-21       Impact factor: 4.314

2.  Modelling FUS Mislocalisation in an In Vitro Model of Innervated Human Muscle.

Authors:  Sonja Prpar Mihevc; Mojca Pavlin; Simona Darovic; Marko Živin; Matej Podbregar; Boris Rogelj; Tomaz Mars
Journal:  J Mol Neurosci       Date:  2017-06-15       Impact factor: 3.444

3.  Novel atomic force microscopy based biopanning for isolation of morphology specific reagents against TDP-43 variants in amyotrophic lateral sclerosis.

Authors:  Stephanie M Williams; Lalitha Venkataraman; Huilai Tian; Galam Khan; Brent T Harris; Michael R Sierks
Journal:  J Vis Exp       Date:  2015-02-12       Impact factor: 1.355

Review 4.  Activating Autophagy as a Therapeutic Strategy for Parkinson's Disease.

Authors:  Alan J Fowler; Charbel E-H Moussa
Journal:  CNS Drugs       Date:  2018-01       Impact factor: 5.749

5.  Human APOE genotype affects intraneuronal Aβ1-42 accumulation in a lentiviral gene transfer model.

Authors:  Wenjuan Zhao; Sonya B Dumanis; Irfan Y Tamboli; Gustavo A Rodriguez; Mary Jo Ladu; Charbel E H Moussa; G William Rebeck
Journal:  Hum Mol Genet       Date:  2013-10-23       Impact factor: 6.150

6.  An acetylation switch controls TDP-43 function and aggregation propensity.

Authors:  Todd J Cohen; Andrew W Hwang; Clark R Restrepo; Chao-Xing Yuan; John Q Trojanowski; Virginia M Y Lee
Journal:  Nat Commun       Date:  2015-01-05       Impact factor: 14.919

Review 7.  TDP-43/FUS in motor neuron disease: Complexity and challenges.

Authors:  Erika N Guerrero; Haibo Wang; Joy Mitra; Pavana M Hegde; Sara E Stowell; Nicole F Liachko; Brian C Kraemer; Ralph M Garruto; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2016-09-28       Impact factor: 11.685

8.  Parkin reverses TDP-43-induced cell death and failure of amino acid homeostasis.

Authors:  Michaeline Hebron; Wenqiang Chen; Matthew J Miessau; Irina Lonskaya; Charbel E-H Moussa
Journal:  J Neurochem       Date:  2013-12-19       Impact factor: 5.372

9.  Pathogenic mutation in the ALS/FTD gene, CCNF, causes elevated Lys48-linked ubiquitylation and defective autophagy.

Authors:  Albert Lee; Stephanie L Rayner; Serene S L Gwee; Alana De Luca; Hamideh Shahheydari; Vinod Sundaramoorthy; Audrey Ragagnin; Marco Morsch; Rowan Radford; Jasmin Galper; Sarah Freckleton; Bingyang Shi; Adam K Walker; Emily K Don; Nicholas J Cole; Shu Yang; Kelly L Williams; Justin J Yerbury; Ian P Blair; Julie D Atkin; Mark P Molloy; Roger S Chung
Journal:  Cell Mol Life Sci       Date:  2017-08-29       Impact factor: 9.261

Review 10.  Linking traumatic brain injury to chronic traumatic encephalopathy: identification of potential mechanisms leading to neurofibrillary tangle development.

Authors:  Brandon Peter Lucke-Wold; Ryan Coddington Turner; Aric Flint Logsdon; Julian Edwin Bailes; Jason Delwyn Huber; Charles Lee Rosen
Journal:  J Neurotrauma       Date:  2014-04-11       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.